---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-088079"
form_type: "8-K"
ticker: "COLL"
cik: "0001267565"
company_name: "COLLEGIUM PHARMACEUTICAL, INC"
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T03:48:16.971294+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Collegium enters $50M accelerated share repurchase under $100M buyback program

## Summary
- $50 million ASR agreement with Jefferies LLC; initial delivery of ~1.7M shares (80% of expected) based on $23.49 close
- Final settlement expected in Q4 2023 based on volume-weighted average price during term
- Part of $100M share repurchase program authorized by Board in January 2023
- As of June 30, 2023, approximately 34.7 million shares outstanding

## SEC filing metadata
- accession: 0001104659-23-088079
- form_type: 8-K
- ticker: COLL
- cik: 0001267565
- company_name: COLLEGIUM PHARMACEUTICAL, INC
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1267565/000110465923088079/0001104659-23-088079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1267565/000110465923088079/tm2323003d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-088079
- JSON: https://secwatch.observer/filing/0001104659-23-088079.json
- Plain text: https://secwatch.observer/filing/0001104659-23-088079.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.